List of Response Genetics patents | 6 results

Name	Description	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 7132238 Method of determining a chemotherapeutic regimen based on ERCC1 expression	Patent 7132238 was granted and assigned to Response Genetics on November, 2006 by the United States Patent and Trademark Office.	Response Genetics	United States Patent and Trademark Office	7132238	November 7, 2006
‌ US Patent 8728763 Methods, primers, probes and kits useful for the detection of BRAF mutations	Patent 8728763 was granted and assigned to Response Genetics on May, 2014 by the United States Patent and Trademark Office.	Response Genetics	United States Patent and Trademark Office	8728763	May 20, 2014
‌ US Patent 8977506 Systems and methods for detecting biological features	Patent 8977506 was granted and assigned to Response Genetics on March, 2015 by the United States Patent and Trademark Office.	Response Genetics	United States Patent and Trademark Office	8977506	March 10, 2015
‌ US Patent 8026062 Method of determining a chemotherapeutic regimen by assaying gene expression in primary tumors	Patent 8026062 was granted and assigned to Response Genetics on September, 2011 by the United States Patent and Trademark Office.	Response Genetics	United States Patent and Trademark Office	8026062	September 27, 2011
‌ US Patent 8586311 Method of determining a chemotherapeutic regimen based on ERCC1 and TS expression	Patent 8586311 was granted and assigned to Response Genetics on November, 2013 by the United States Patent and Trademark Office.	Response Genetics	United States Patent and Trademark Office	8586311	November 19, 2013
‌ US Patent 7049059 Method of determining a chemotherapeutic regimen based on ERCC1 and TS expression	Patent 7049059 was granted and assigned to Response Genetics on May, 2006 by the United States Patent and Trademark Office.	Response Genetics	United States Patent and Trademark Office	7049059	May 23, 2006